A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

Nicole Fram M.D.

Status: Completed

Conditions: Cataract Senile; Corneal Edema; Ocular Pain; Nuclear Cataract; Anterior Chamber Inflammation; Corneal Defect; Cortical Cataract; Penetrating KeratoPlasty

Treatments: Drug: Dextenza 0.4Mg Ophthalmic Insert

Study type: Observational

Funder types: Other

Identifiers

NCT04975971

AVC-004

Details and patient eligibility

About

A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal transplant or Cataract surgery

Full description

A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert, placed within the lower or upper eye lid canaliculus in conjunction with topical steroid Prior to or Following Corneal transplant or Cataract surgery

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 years and older
• Patients who received DEXTENZA insertion perioperatively.

Exclusion criteria

• Any patient who did not receive DEXTENZA insertion

Trial design

25 participants in 1 patient group

Dextenza recepient

Description:

A Retrospective Review DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal Transplant or Cataract Surgery

Treatment:

Drug: Dextenza 0.4Mg Ophthalmic Insert